Cargando…
Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system
A biocompatible nanocarrier system was prepared in this research through the reaction of calcium alginate (CA) with chitosan (CS). The structure of developed nanocarriers (CS-CA) was characterized by thermogravimetric analysis (TGA), Fourier transforms infrared (FT-IR) spectroscopy, field emission s...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503968/ https://www.ncbi.nlm.nih.gov/pubmed/37720607 http://dx.doi.org/10.55730/1300-0527.3370 |
_version_ | 1785106623404965888 |
---|---|
author | RAMAZANZADEH, Nasim MAHMOODI, Nosrat O. |
author_facet | RAMAZANZADEH, Nasim MAHMOODI, Nosrat O. |
author_sort | RAMAZANZADEH, Nasim |
collection | PubMed |
description | A biocompatible nanocarrier system was prepared in this research through the reaction of calcium alginate (CA) with chitosan (CS). The structure of developed nanocarriers (CS-CA) was characterized by thermogravimetric analysis (TGA), Fourier transforms infrared (FT-IR) spectroscopy, field emission scanning electron microscopy (FE-SEM), X-ray diffraction (XRD) atomic force microscopy (AFM), and transmission electron microscopy (TEM). Swelling properties of CS-CA and CA, and their ability for loading and in vitro release of empagliflozin (EMP) were also investigated. The results showed the higher loading capacity of CS-CA compared to CA. For both nanocarriers, the drug release was higher at neutral pH (7.4 and 6.8) when compared to acidic pH (1.2). Despite the higher release of CA than CS-CA, the latter exhibited a favorable sustained drug release in all pH levels. As a result, CS-CA nanocarrier (EMP@CS-CANC) can be suggested as a new candidate for colon drug delivery of EMP. |
format | Online Article Text |
id | pubmed-10503968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Scientific and Technological Research Council of Turkey (TUBITAK) |
record_format | MEDLINE/PubMed |
spelling | pubmed-105039682023-09-16 Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system RAMAZANZADEH, Nasim MAHMOODI, Nosrat O. Turk J Chem Research Article A biocompatible nanocarrier system was prepared in this research through the reaction of calcium alginate (CA) with chitosan (CS). The structure of developed nanocarriers (CS-CA) was characterized by thermogravimetric analysis (TGA), Fourier transforms infrared (FT-IR) spectroscopy, field emission scanning electron microscopy (FE-SEM), X-ray diffraction (XRD) atomic force microscopy (AFM), and transmission electron microscopy (TEM). Swelling properties of CS-CA and CA, and their ability for loading and in vitro release of empagliflozin (EMP) were also investigated. The results showed the higher loading capacity of CS-CA compared to CA. For both nanocarriers, the drug release was higher at neutral pH (7.4 and 6.8) when compared to acidic pH (1.2). Despite the higher release of CA than CS-CA, the latter exhibited a favorable sustained drug release in all pH levels. As a result, CS-CA nanocarrier (EMP@CS-CANC) can be suggested as a new candidate for colon drug delivery of EMP. Scientific and Technological Research Council of Turkey (TUBITAK) 2022-02-03 /pmc/articles/PMC10503968/ /pubmed/37720607 http://dx.doi.org/10.55730/1300-0527.3370 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Research Article RAMAZANZADEH, Nasim MAHMOODI, Nosrat O. Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
title | Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
title_full | Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
title_fullStr | Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
title_full_unstemmed | Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
title_short | Drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
title_sort | drug delivery system for controlled release of empagliflozin from alginate-chitosan nanocarrier system |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503968/ https://www.ncbi.nlm.nih.gov/pubmed/37720607 http://dx.doi.org/10.55730/1300-0527.3370 |
work_keys_str_mv | AT ramazanzadehnasim drugdeliverysystemforcontrolledreleaseofempagliflozinfromalginatechitosannanocarriersystem AT mahmoodinosrato drugdeliverysystemforcontrolledreleaseofempagliflozinfromalginatechitosannanocarriersystem |